Clinical Trial Update: Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab [Phase 4]

View source ↗

Summary

A Phase 4 study assessing the immunogenicity of a herpes zoster subunit vaccine in inflammatory bowel disease patients treated with vedolizumab; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Herpes Zoster
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Entyvio (vedolizumab)
• Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Inflammatory Bowel Diseases, Crohn Disease | Phase 4 | Status: COMPLETED | Results posted: 2025-04-02